Compare CCEL & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEL | IPWR |
|---|---|---|
| Founded | 1989 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 26.3M |
| IPO Year | 1997 | 2013 |
| Metric | CCEL | IPWR |
|---|---|---|
| Price | $3.45 | $3.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 15.3K | ★ 78.1K |
| Earning Date | 02-27-2026 | 02-26-2026 |
| Dividend Yield | ★ 11.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $31,747,500.00 | $43,136.00 |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | $3,233.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.10 | $2.76 |
| 52 Week High | $8.79 | $7.71 |
| Indicator | CCEL | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 42.03 | 55.61 |
| Support Level | $3.35 | $3.15 |
| Resistance Level | $3.50 | $4.24 |
| Average True Range (ATR) | 0.25 | 0.40 |
| MACD | 0.01 | 0.08 |
| Stochastic Oscillator | 33.48 | 59.39 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.